natgillin/translations-raw huggingface dataset:
The MSC reached a unanimous agreement on the identification of DEHP as having endocrine disrupting properties for which there is scientific evidence of probable serious effects to the environment which give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006.
Odbor država članica postigao je suglasnost o označivanju DEHP-a kao tvari sa svojstvima endokrine disrupcije za koje postoje znanstveni dokazi o vjerojatnim ozbiljnim učincima na okoliš koji izazivaju jednaku zabrinutost u skladu s člankom 57. točkom (f) Uredbe (EZ) br. 1907/2006.
Accordingly the Agency amended the DEHP entry in the candidate list on 17 December 2014.
U skladu s tim Agencija je 17. prosinca 2014. izmijenila unos DEHP-a na popisu tvari predloženih za uvrštenje.
The MSC unanimously acknowledged that for DEHP, BBP, DBP and DIBP there is scientific evidence on the endocrine activity and on the link between this activity and the adverse effects to human health and further, that the substances can be considered endocrine disruptors for human health as they fulfil the WHO/IPCS definition for an endocrine disruptor and the recommendations from the European Commission's Expert Advisory Group for a substance to be identified as an endocrine disruptor.
Odbor država članica je jednoglasno potvrdio postojanje znanstvenih dokaza o svojstvima endokrine disrupcije DEHP-a, BBP-a, DBP-a i DIBP-a te uzročno-posljedične povezanosti tih svojstava i štetnih učinaka na zdravlje ljudi te da se te tvari mogu smatrati tvarima sa svojstvima endokrine disrupcije zdravlja ljudi jer ispunjavaju uvjete iz definicije endokrinog disruptora Svjetske zdravstvene organizacije i Međunarodnog programa za sigurnost kemikalija, kao i preporuka Stručne savjetodavne skupine Europske komisije o označivanju tvari kao endokrinih disruptora.
However, the MSC did not reach unanimous agreement on the identification of the four substances under Article 57(f) of Regulation (EC) No 1907/2006 as giving rise to an equivalent level of concern to those of other substances listed in points (a) to (c) of that Article due to endocrine disrupting properties in relation to human health.
No Odbor država članica nije postigao jednoglasan dogovor o označivanju četiri tvari u skladu s člankom 57. točkom (f) Uredbe (EZ) br. 1907/2006 kao tvari koje izazivaju jednaku zabrinutost kao i ostale tvari navedene u istom članku u točkama od (a) do (c), zbog svojstava endokrine disrupcije u odnosu na zdravlje ljudi.
According to four members of the MSC the effects for human health pointed out in the Annex XV dossiers were the same effects, caused by the same mode of action, as those already taken into account when the substances were included in the candidate list due to their toxicity for reproduction according to Article 57(c) of that Regulation.
Četiri člana Odbora istaknula su da su učinci na zdravlje ljudi navedeni u dokumentaciji u skladu s Prilogom XV. isti učinci, uzrokovani istim načinom djelovanja, kao i učinci koji su već uzeti u obzir pri njihovom stavljanju na popis tvari predloženih za uvrštenje zbog njihove reproduktivne toksičnosti u skladu s člankom 57. točkom (c) te Uredbe.
On 20 February 2015, pursuant to Article 59(9) of Regulation (EC) No 1907/2006, the MSC referred its opinion to the Commission for a decision on the identification of the four substances as having endocrine disrupting properties for human health giving rise to an equivalent level of concern according to Article 57(f).
Dana 20. veljače 2015. Odbor država članica je, u skladu s člankom 59. stavkom 9. Uredbe (EZ) br. 1907/2006, uputio svoje stajalište Komisiji radi odluke o označivanju četiri tvari kao tvari sa svojstvima endokrine disrupcije čiji učinci izazivaju jednaku zabrinutost u skladu s člankom 57. točkom (f).
The Commission notes the unanimous agreement in MSC that the four substances have endocrine disrupting properties and that the adverse effects caused by this mode of action are the same effects that led to their classification as toxic for reproduction and their identification as substances of very high concern according to Article 57(c) of Regulation (EC) No 1907/2006.
Komisija navodi jednoglasno stajalište Odbora država članica o tome da četiri tvari imaju svojstva endokrine disrupcije i da su njihovi štetni učinci uzrokovani tim načinom djelovanja jednaki učincima koji su doveli do razvrstavanja među reproduktivno toksične tvari i o njihovom označivanju kao tvarima vrlo zabrinjavajućih svojstava u skladu s člankom 57. točkom (c) Uredbe (EZ) br. 1907/2006.
The Commission also notes that the majority of members of the MSC considered that the level of concern of those effects is equivalent to those of substances referred to in Article 57(a) to (e).
Osim toga, Komisija navodi da većina članova Odbora država članica smatra da ti učinci izazivaju jednaku razinu zabrinutosti kao i učinci ostalih tvari navedenih u članku 57. točkama od (a) do (e).
The Commission notes that Article 57 does not preclude identifying a substance as being of very high concern several times based on more than one intrinsic property causing the same effect on human health.
Komisija navodi da se člankom 57. ne isključuje označivanje tvari kao tvari vrlo zabrinjavajućih svojstava nekoliko puta na temelju istog učinka na zdravlje ljudi.
Therefore DEHP, BBP, DBP and DIBP should be identified under Article 57(f) as substances of very high concern due to their endocrine disrupting properties for which there is scientific evidence of probable serious effects to human health which give rise to an equivalent level of concern to those of other substances listed in paragraph(s) (a) to (e) of that Article.
Stoga bi DEHP, DBP, BBP i DIBP trebalo označiti kao tvari vrlo zabrinjavajućih svojstava u skladu s člankom 57. točkom (f) zbog svojstava endokrine disrupcije za koje postoje znanstveni dokazi o vjerojatnim ozbiljnim učincima na zdravlje ljudi koji su jednako zabrinjavajući kao i učinci ostalih tvari navedenih u tom članku u točkama od (a) do (e).
This Decision is without prejudice to the outcome of the on-going activities related to the definition of criteria for the identification of endocrine disruptors in accordance with the provisions of Regulation (EC) No 1107/2009 of the European Parliament and of the Council [3], and Regulation (EU) No 528/2012 of the European Parliament and of the Council [4].
Ovom se Odlukom ne dovode u pitanje rezultati aktivnosti u tijeku povezanih s definiranjem kriterija za utvrđivanje endokrinih disruptora u skladu s odredbama Uredbe (EZ) br. 1107/2009 Europskog parlamenta i Vijeća [3], kao i odredbama Uredbe (EU) br. 528/2012 Europskog parlamenta i Vijeća [4].
The measures provided for in this Decision are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,
Mjere predviđene ovom Odlukom u skladu su s mišljenjem Odbora osnovanog na temelju članka 133. Uredbe (EZ) br. 1907/2006,
The following substances are identified as substances having endocrine disrupting properties whose effects to human health give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006:
Sljedeće tvari označuju se kao tvari sa svojstvima endokrine disrupcije čiji učinci na zdravlje ljudi izazivaju jednaku zabrinutost u skladu s člankom 57. točkom (f) Uredbe (EZ) br. 1907/2006:
Bis(2-ethylhexyl) phthalate (DEHP), (EC No 204-211-0, CAS No 117-81-7)
bis(2-etilheksil)-ftalat (DEHP), (EZ br. 204-211-0, CAS br. 117-81-7),
Dibutyl phthalate (DBP) (EC No 201-557-4, CAS No 84-74-2)
dibutil-ftalat (DBP) (EZ br. 201-557-4, CAS br. 84-74-2),
Benzyl butyl phthalate (BBP) (EC No 201-622-7, CAS No 85-68-7)
benzil butil ftalat (BBP) (EZ br. 201-622-7, CAS br. 85-68-7),
Diisobutyl phthalate (DIBP) (EC No 201-553-2, CAS No 84-69-5)
diizobutil ftalat (DIBP) (EZ br. 201-553-2, CAS br. 84-69-5).
The entry of the substances specified in paragraph 1 in the candidate list referred to in Article 59(1) of Regulation (EC) No 1907/2006 shall be amended by adding, under ‘Reason for inclusion’, ‘Equivalent level of concern having probable serious effects to human health’.
Unos tvari iz stavka 1. na popisu tvari predloženih za uvrštenje iz članka 59. stavka 1. Uredbe (EZ) br. 1907/2006 mijenja se dodavanjem, pod „razlog uvrštenja”, sljedećeg teksta: „jednaka razina zabrinutosti s vjerojatnim ozbiljnim učincima na zdravlje ljudi”.
This Decision is addressed to the European Chemicals Agency.
Ova je Odluka upućena Europskoj agenciji za kemikalije.
Commission Implementing Decision (EU) 2017/1211
Provedbena odluka Komisije (EU) 2017/1211
authorising the placing on the market of products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 (DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
o odobravanju stavljanja na tržište proizvoda koji sadržavaju genetski modificirani pamuk 281-24-236 × 3006-210-23 × MON 88913 (DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8), sastoje se ili su proizvedeni od njega na temelju Uredbe (EZ) br. 1829/2003 Europskog parlamenta i Vijeća
(notified under document C(2017) 4495)
(priopćeno pod brojem dokumenta C(2017) 4495)
On 12 March 2009, Dow AgroSciences Europe submitted to the competent authority of The Netherlands an application, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003, for the placing on the market of foods, food ingredients, and feed containing, consisting of, or produced from 281-24-236 × 3006-210-23 × MON 88913 cotton.
Društvo Dow AgroSciences Europe podnijelo je 12. ožujka 2009. nadležnom tijelu Nizozemske, u skladu s člancima 5. i 17. Uredbe (EZ) br. 1829/2003, zahtjev za stavljanje na tržište hrane, sastojaka hrane i hrane za životinje koji sadržavaju pamuk 281-24-236 × 3006-210-23 × MON 88913, sastoje se ili su proizvedeni od njega.
The application also covers the placing on the market of 281-24-236 × 3006-210-23 × MON 88913 cotton in products consisting of it or containing it for any other uses than food and feed as any other cotton, with the exception of cultivation.
Zahtjev obuhvaća i stavljanje na tržište pamuka 281-24-236 × 3006-210-23 × MON 88913 u proizvodima koji se sastoje od njega ili ga sadržavaju te se, osim za hranu i hranu za životinje, koristi kao i ostali pamuk, osim uzgoja.
In accordance with Article 5(5) and Article 17(5) of Regulation (EC) No 1829/2003, the application includes the data and information required by Annexes III and IV to Directive 2001/18/EC of the European Parliament and of the Council [2] and information and conclusions about the risk assessment carried out in accordance with the principles set out in Annex II to Directive 2001/18/EC.
U skladu s člankom 5. stavkom 5. i člankom 17. stavkom 5. Uredbe (EZ) br. 1829/2003 zahtjev sadržava podatke i informacije koji su potrebni u skladu s prilozima III. i IV. Direktivi 2001/18/EZ Europskog parlamenta i Vijeća [2] te informacije i zaključke o procjeni rizika provedenoj u skladu s načelima utvrđenima u Prilogu II. Direktivi 2001/18/EZ.
On 8 April 2016, the European Food Safety Authority (‘EFSA’) issued a favourable opinion [3] in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003.
Europska agencija za sigurnost hrane („EFSA”) izdala je 8. travnja 2016. pozitivno mišljenje [3] u skladu s člancima 6. i 18. Uredbe (EZ) br. 1829/2003.
It concluded that genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 is as safe and as nutritious as its conventional counterpart in the context of its intended uses.
Zaključila je da je genetski modificirani pamuk 281-24-236 × 3006-210-23 × MON 88913 jednako siguran i hranjiv kao njegov konvencionalni ekvivalent u kontekstu njegove predviđene namjene.
In its opinion, EFSA considered all the specific questions and concerns raised by the Member States in the context of the consultation of the national competent authorities as provided for by Article 6(4) and Article 18(4) of Regulation (EC) No 1829/2003.
EFSA je u svojem mišljenju uzela u obzir sva specifična pitanja i dvojbe država članica koji su izneseni u okviru savjetovanja s nacionalnim nadležnim tijelima, kako je predviđeno u članku 6. stavku 4. i članku 18. stavku 4. Uredbe (EZ) br. 1829/2003.
In its opinion, EFSA also concluded that the environmental monitoring plan, consisting of a general surveillance plan, submitted by the applicant is in line with the intended uses of the products.
EFSA je u svojem mišljenju zaključila i da je plan praćenja stanja okoliša koji je dostavio podnositelj zahtjeva i koji se sastoji od općeg plana nadzora u skladu s predviđenim namjenama proizvoda.
Taking into account those considerations, authorisation should be granted to the products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913.
Uzimajući u obzir navedeno, potrebno je odobriti proizvode koji sadržavaju genetski modificirani pamuk 281-24-236 × 3006-210-23 × MON 88913, sastoje se ili su proizvedeni od njega.
A unique identifier should be assigned to genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 in accordance with Commission Regulation (EC) No 65/2004 [4].
Genetski modificiranom pamuku 281-24-236 × 3006-210-23 × MON 88913 trebalo bi dodijeliti jedinstveni identifikacijski kôd, kako je predviđeno u Uredbi Komisije (EZ) br. 65/2004 [4].
On the basis of the EFSA opinion, no specific labelling requirements other than those provided for in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003 appear to be necessary for foods, food ingredients and feed containing, consisting of, or produced from cotton 281-24-236 × 3006-210-23 × MON 88913.
Na temelju mišljenja EFSA-e nisu potrebni posebni zahtjevi označivanja za hranu, sastojke hrane i hranu za životinje koja sadržava pamuk 281-24-236 × 3006-210-23 × MON 88913, sastoji se ili je proizvedena od njega, osim onih koji su propisani člankom 13. stavkom 1. i člankom 25. stavkom 2 Uredbe (EZ) br. 1829/2003.
However, in order to ensure the use of the products containing or consisting of cotton 281-24-236 × 3006-210-23 × MON 88913 within the limits of the authorisation provided for by this Decision, the labelling of those products, with the exception of food products, should be complemented by a clear indication that the products in question must not be used for cultivation.
Ipak, kako bi se zajamčilo da se proizvodi koji sadržavaju pamuk 281-24-236 × 3006-210-23 × MON 88913 ili se od njega sastoje upotrebljavaju u okviru granica odobrenja predviđenog ovom Odlukom, pri označivanju tih proizvoda, osim prehrambenih proizvoda, trebalo bi jasno istaknuti da se proizvodi u pitanju ne smiju upotrebljavati za uzgoj.
All relevant information on the authorisation of the products should be entered in the Community register of genetically modified food and feed referred to in Regulation (EC) No 1829/2003.
Sve relevantne informacije o odobrenju proizvoda trebalo bi upisati u registar Zajednice genetski modificirane hrane i hrane za životinje iz Uredbe (EZ) br. 1829/2003.
Genetically modified cotton (Gossypium hirsutum L.) 281-24-236 × 3006-210-23 × MON 88913, as specified in point (b) of the Annex to this Decision, is assigned the unique identifier DAS-24236-5×DAS-21Ø23-5×MON-88913-8, in accordance with Regulation (EC) No 65/2004.
Genetski modificiranom pamuku (Gossypium hirsutum L.) 281-24-236 × 3006-210-23 × MON 88913, kako je navedeno u točki (b) Priloga ovoj Odluci, dodjeljuje se jedinstveni identifikacijski kôd DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8, u skladu s Uredbom (EZ) br. 65/2004.
foods and food ingredients containing, consisting of, or produced from DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton;
hrana i sastojci hrane koji sadržavaju pamuk DAS-24236-5×DAS-21Ø23-5×MON-88913-8, sastoje se ili su proizvedeni od njega;
feed containing, consisting of, or produced from DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton;
hrana za životinje koja sadržava pamuk DAS-24236-5×DAS-21Ø23-5×MON-88913-8, sastoji se ili je proizvedena od njega;
DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton in products containing it or consisting of it for any other use than (a) and (b), with the exception of cultivation.
pamuk DAS-24236-5×DAS-21Ø23-5×MON-88913-8 u proizvodima koji ga sadržavaju ili se od njega sastoje te se upotrebljavaju za druge namjene od onih iz točaka (a) i (b), osim uzgoja.
For the purposes of the labelling requirements laid down in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003 and in Article 4(6) of Regulation (EC) No 1830/2003 of the European Parliament and of the Council [6], the ‘name of the organism’ shall be ‘cotton’.
Za potrebe zahtjeva označivanja utvrđenih u članku 13. stavku 1. i članku 25. stavku 2. Uredbe (EZ) br. 1829/2003 te u članku 4. stavku 6. Uredbe (EZ) br. 1830/2003 Europskog parlamenta i Vijeća [6], „naziv organizma” jest „pamuk”.
The words ‘not for cultivation’ shall appear on the label of and in the documents accompanying products containing or consisting of DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton with the exception of the products referred to in point (a) of Article 2.
Riječi „ne za uzgoj” navode se na oznaci i u popratnim dokumentima proizvoda koji sadržavaju pamuk DAS-24236-5×DAS-21Ø23-5×MON-88913-8 ili se sastoje od njega, osim proizvoda iz članka 2. točke (a).
The authorisation holder shall submit to the Commission annual reports on the implementation and the results of the activities set out in the monitoring plan in accordance with the format set out in Decision 2009/770/EC.
Nositelj odobrenja Komisiji podnosi godišnja izvješća o provedbi i rezultatima aktivnosti utvrđenih u planu praćenja u skladu s formatom utvrđenim u Odluci 2009/770/EZ.
The information set out in the Annex to this Decision shall be entered in the Community register of genetically modified food and feed referred to in Article 28 of Regulation (EC) No 1829/2003.
Informacije iz Priloga ovoj Odluci upisuju se u registar Zajednice genetski modificirane hrane i hrane za životinje iz članka 28. Uredbe (EZ) br. 1829/2003.
The authorisation holder shall be Dow AgroSciences Europe, United Kingdom, representing Mycogen Seeds, United States.
Nositelj odobrenja jest društvo Dow AgroSciences Europe, Ujedinjena Kraljevina, koje zastupa društvo Mycogen Seeds, Sjedinjene Američke Države.
This Decision is addressed to Dow AgroSciences Europe, European Development Centre 3 Milton Park, Abingdon, Oxon OX14 4RN, United Kingdom
Ova je Odluka upućena društvu Dow AgroSciences Europe, European Development Centre 3 Milton Park, Abingdon, Oxon OX14 4RN, Ujedinjena Kraljevina
EFSA Journal 2016; 14(4):4430, 21 pp. doi:10.2903/j.efsa.2016.4430.
EFSA Journal 2016.; 14(4):4430, 21 str. doi:10.2903/j.efsa.2016.4430.
Name Dow AgroSciences Europe, representing Mycogen Seeds, United States.
Naziv Dow AgroSciences Europe, koji zastupa Mycogen Seeds, Sjedinjene Američke Države.
Address Dow AgroSciences Europe, European Development Centre 3 Milton Park, Abingdon, Oxon OX14 4RN, United Kingdom
Adresa Dow AgroSciences Europe, European Development Centre 3 Milton Park, Abingdon, Oxon OX14 4RN, Ujedinjena Kraljevina
DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton in products containing it or consisting of it for any other than (1) and (2), with the exception of cultivation.
pamuk DAS-24236-5×DAS-21Ø23-5×MON-88913-8 u proizvodima koji ga sadržavaju ili se od njega sastoje te se upotrebljavaju za druge namjene od onih iz točaka 1. i 2., osim uzgoja.
The genetically modified DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton, as described in the application, expresses the phosphinothricin acetyl transferase (PAT) protein which confers tolerance to glufosinate-ammonium herbicides and the modified CP4 5-enolpyruvyl-shikimate-3-phosphate synthase (CP4EPSPS) protein which confers tolerance to glyphosate herbicides, Cry1F and Cry1Ac proteins, conferring protection against certain lepidopteran insect pests.
Genetski modificiran pamuk DAS-24236-5×DAS-21Ø23-5×MON-88913-8, kako je opisan u zahtjevu, eksprimira protein fosfinotricin-acetil-transferaza (PAT), koji uzrokuje toleranciju na herbicide glufosinat-amonij i na modificirani protein CP4 5-enolpiruvilšikimat-3-fosfatsintazu (CP4EPSPS), koji uzrokuje toleranciju na herbicid glifosat te proteine Cry1F i Cry1Ac, čime uzrokuje zaštitu od određenih insekata štetnika iz reda Lepidoptera.
For the purposes of the labelling requirements laid down in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003, and in Article 4(6) of Regulation (EC) No 1830/2003, the ‘name of the organism’ shall be ‘cotton’;
Za potrebe zahtjeva označivanja utvrđenih u članku 13. stavku 1. i članku 25. stavku 2. Uredbe (EZ) br. 1829/2003 te u članku 4. stavku 6. Uredbe (EZ) br. 1830/2003 „naziv organizma” jest „pamuk”;
The words ‘not for cultivation’ shall appear on the label of and in documents accompanying products containing or consisting of DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton with the exception of products referred to in point (a) of Article 2.
Riječi „ne za uzgoj” navode se na oznaci i u popratnim dokumentima proizvoda koji sadržavaju pamuk DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8 ili se sastoje od njega, osim proizvoda iz članka 2. točke (a).
Event specific real-time quantitative PCR based methods for DAS-24236-5, DAS-21Ø23-5 and MON-88913-8 cottons; the detection methods have been validated on genomic DNA extracted from seeds DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton and on genomic DNA extracted from seeds of the single-trait events and verified on genomic DNA extracted from seeds of DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton;
specifične kvantitativne metode za otkrivanje pamuka DAS-24236-5, DAS-21Ø23-5 i MON-88913-8 na temelju lančane reakcije s polimerazom (PCR) u stvarnom vremenu; metode otkrivanja potvrđene su na genomskom DNK-u iz sjemena pamuka DAS-24236-5×DAS-21Ø23-5×MON-88913-8 i na genomskom DNK-u iz sjemena pojedinačnih promjena te provjerene na genomskom DNK-u iz sjemena pamuka DAS-24236-5×DAS-21Ø23-5×MON-88913-8;
ERM®-BF422 for 281-24-236 × 3006-210-23 cotton is accessible via accessible via the Joint Research Centre (JRC) of the European Commission, Institute for Reference Materials and Measurements (IRMM) at https://crm.jrc.ec.europa.eu/ and
ERM®-BF422 za pamuk 281-24-236 × 3006-210-23 dostupan je preko Instituta za referentne materijale i mjerenja (IRMM) u okviru Zajedničkog istraživačkog centra (ZIC) Europske komisije na https://crm.jrc.ec.europa.eu/, a
AOCS 0906-D and AOCS 0804-A for MON 88913 cotton is accessible via the American Oil Chemists Society at https://www.aocs.org/crm
AOCS 0906-D i AOCS 0804-A za pamuk MON 88913 dostupni su preko Američkog udruženja naftnih kemičara na https://www.aocs.org/crm.
Scientific Opinion on application EFSA-GMO-NL-2012-68 for the placing on the market of genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 for food and feed uses, import and processing under Regulation (EC) No 1829/2003.
Znanstveno mišljenje o zahtjevu EFSA-GMO-NL-2012-68 za stavljanje na tržište genetski modificiranog pamuka 281-24-236 × 3006-210-23 × MON 88913 za uporabu u hrani i hrani za životinje, uvoz i obradu u skladu s Uredbom (EZ) br. 1829/2003.
Commission Implementing Decision (EU) 2017/1212
Provedbena odluka Komisije (EU) 2017/1212
authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European parliament and of the Council on genetically modified food and feed
o odobravanju stavljanja na tržište proizvoda koji sadržavaju genetski modificirani kukuruz DAS-40278-9 ili se sastoje ili su proizvedeni od njega, na temelju Uredbe (EZ) br. 1829/2003 Europskog parlamenta i Vijeća o genetski modificiranoj hrani i hrani za životinje
(notified under document C(2017) 4503)
(priopćeno pod brojem dokumenta C(2017) 4503)